Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
BACKGROUND: Thrombolytic therapy improves survival after myocardial infarction through reperfusion of the infarct-related artery. Thrombin generated during thrombolytic administration may reduce the efficacy of thrombolysis. A direct thrombin inhibitor may improve early patency rates. METHODS AND RE...
Main Authors: | White, H, Aylward, P, Frey, M, Adgey, A, Nair, R, Hillis, W, Shalev, Y, Brown, M, French, J, Collins, R, Maraganore, J, Adelman, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1997
|
Similar Items
-
A review of the pharmacology clinical applications, and toxicology of hirudin and hirulog /
by: Hand, R. -
RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
by: Collins, R, et al.
Published: (1987) -
RANDOMIZED FACTORIAL TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
by: Collins, R
Published: (1987) -
Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study.
by: Collins, R
Published: (1987) -
HERO /
by: Hilal Asyraf, 1989-, author
Published: (2017)